What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Yasuo Morishima mainly investigates Immunology, Internal medicine, Lymphoma, Transplantation and Leukemia. Yasuo Morishima works mostly in the field of Immunology, limiting it down to topics relating to Allele and, in certain cases, Genotype, Single-nucleotide polymorphism and Pathogenesis. His studies in Internal medicine integrate themes in fields like Gastroenterology, Surgery and Oncology.
Lymphoma is a subfield of Pathology that he tackles. His Transplantation research is multidisciplinary, incorporating elements of Histocompatibility and Hazard ratio. His Leukemia research is multidisciplinary, relying on both Bone marrow and Aggressive NK-cell leukemia.
His most cited work include:
- Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor (486 citations)
- The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. (413 citations)
- A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. (322 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Immunology, Transplantation, Gastroenterology and Surgery. His Internal medicine study frequently draws parallels with other fields, such as Oncology. His Immunology study incorporates themes from Single-nucleotide polymorphism, Genotype and Disease.
The study incorporates disciplines such as Incidence, Cumulative incidence, Hematology, Retrospective cohort study and Bone marrow in addition to Transplantation. His Gastroenterology research is multidisciplinary, incorporating perspectives in International Prognostic Index, Lymphoma, Rituximab, Phases of clinical research and Survival rate. His Human leukocyte antigen study combines topics from a wide range of disciplines, such as Minor histocompatibility antigen, Genotyping and Allele, Haplotype.
He most often published in these fields:
- Internal medicine (57.26%)
- Immunology (36.31%)
- Transplantation (34.85%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (57.26%)
- Transplantation (34.85%)
- Hematopoietic stem cell transplantation (21.99%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Immunology and Oncology are his primary areas of study. His research in Internal medicine intersects with topics in Gastroenterology and Surgery. His work carried out in the field of Transplantation brings together such families of science as Incidence, Cumulative incidence, Myeloid leukemia, Stem cell and Leukemia.
His Hematopoietic stem cell transplantation research includes elements of Cancer, Performance status, Transplantation Conditioning and Myelodysplastic syndromes. His work in the fields of Immunology, such as Human leukocyte antigen, intersects with other areas such as Induced pluripotent stem cell. Yasuo Morishima focuses mostly in the field of Oncology, narrowing it down to matters related to Hematology and, in some cases, Lymphoma.
Between 2013 and 2021, his most popular works were:
- Biological significance of HLA locus matching in unrelated donor bone marrow transplantation. (96 citations)
- Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group. (86 citations)
- Comparison of Outcomes of 8/8 and 7/8 Allele–Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia (68 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
